Acute Recovery of Cardiorespiratory Outcomes After a Cardiovascular Rehabilitation Protocol with Dance Compared to a Conventional Protocol: A Non-Randomized Crossover Clinical Trial.

J Dance Med SciApr 13, 2026 (epub)

Natacha de Lima Gervazoni, João Pedro Lucas Neves Silva, Júlio Cesar de Ávila Soares et al.

✦ AI-curated · Sources linked

In 30 seconds

This nonrandomized crossover clinical trial compared acute cardiorespiratory recovery after treadmill-based conventional cardiac rehabilitation and choreographed dance in 20 women with at least one cardiovascular risk factor. Both protocols included rest, warm-up, resistance exercise, and recovery phases. No significant differences between protocols or time-by-protocol interactions were found for the measured outcomes (P > .05). Across rest and recovery, systolic blood pressure, heart rate, respiratory rate, and perceived exertion changed significantly (P < .001); perceived exertion did not differ between protocols (P = .29).

Key findings

  • No significant between-protocol differences or time-by-protocol interactions were observed for measured outcomes (P > .05).
  • Systolic blood pressure, heart rate, respiratory rate, and perceived exertion differed between rest and recovery (P < .001).
  • Perceived exertion did not differ between dance and conventional protocols (P = .29).

Why it matters

The findings suggest that, in this small group of women with cardiovascular risk factors, dance produced acute physiological recovery outcomes comparable to treadmill-based rehabilitation. Since motivation and adherence can be barriers to cardiac rehabilitation, an alternative exercise format may be relevant to program design, although this study assessed acute responses rather than adherence or longer-term outcomes.

What to keep in mind

The trial was nonrandomized, included only 20 women, and assessed acute recovery rather than longer-term outcomes or adherence.

Source

Published in J Dance Med Sci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.